These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23479965)

  • 1. [The activity of components of system of matrix metalloproteinase and tissue inhibitors of metalloproteinase on different stages of chronic cardiac failure].
    Egorova EN; Kuz'mina MI; Mazur VV; Kalinkin MN; Mazur ES; Gorshkova MA
    Klin Lab Diagn; 2012 Dec; (12):13-4. PubMed ID: 23479965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endotoxinemia and systemic inflammation in pathogenesis of chronic heart failure].
    Egorova EN; Kalinkin MN; Mazur ES
    Patol Fiziol Eksp Ter; 2011; (4):42-6. PubMed ID: 22359933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microbiocenosis and activity of the inflammatory process in the colon of the patients with chronic cardiac failure].
    Egorova EN; Kuz'mina MI; Mazur VV; Kalinkin MN; Mazur ES
    Klin Med (Mosk); 2012; 90(7):46-8. PubMed ID: 23019975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biomarkers in human terminal heart failure and under mechanical circulatory support.
    Kramer F; Milting H
    Biomarkers; 2011 Jul; 16 Suppl 1():S31-41. PubMed ID: 21707442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality.
    Frantz S; Störk S; Michels K; Eigenthaler M; Ertl G; Bauersachs J; Angermann CE
    Eur J Heart Fail; 2008 Apr; 10(4):388-95. PubMed ID: 18343723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between levels of sex hormones and response to cardiac resynchronisation therapy in men].
    Enina TN; Kuznetsov VA; Soldatova AM; Petelina TI; Krinochkin DV; Dyachkov SM; Rychkov AY; Gorbunova TY
    Kardiologiia; 2018 SJul; 58(S7):24-35. PubMed ID: 30081800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha.
    Amir O; Rogowski O; David M; Lahat N; Wolff R; Lewis BS
    Isr Med Assoc J; 2010 Mar; 12(3):158-62. PubMed ID: 20684180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease.
    Dini FL; Buralli S; Bajraktari G; Elezi S; Duranti E; Metelli MR; Carpi A; Taddei S
    Biomed Pharmacother; 2010 May; 64(5):339-42. PubMed ID: 19944559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure.
    Kotlyar E; Vita JA; Winter MR; Awtry EH; Siwik DA; Keaney JF; Sawyer DB; Cupples LA; Colucci WS; Sam F
    J Card Fail; 2006 Mar; 12(2):122-7. PubMed ID: 16520260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trends in systemic inflammatory factors and aminoterminal brain natriuretic propeptide in the treatment of chronic heart failure].
    Egorova EN; Kuz'mina MI; Mazur VV; Kalinkin MN; Mazur ES
    Ter Arkh; 2011; 83(1):56-9. PubMed ID: 21446204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls in the determination of circulating matrix metalloproteinases and their inhibitors by disregarding fundamental laboratory principles.
    Jung K
    Am Heart J; 2013 Jun; 165(6):e31. PubMed ID: 23708179
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammations mediators and circulating levels of matrix metalloproteinases: Biomarkers of diabetes in Tunisians metabolic syndrome patients.
    Zayani Y; El Golli N; Zidi W; Guizani I; Boussairi S; Aloui S; Ayadi I; Ftouhi B; Feki M; Ben Romdhane N; Ben Sliman H; Allal-Elasmi M; Kaabachi N
    Cytokine; 2016 Oct; 86():47-52. PubMed ID: 27455450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
    Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
    Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Features of intestine microbiocenosis and systemic inflammation factors in chronic heart failure patients].
    Egorova EN; Sergeeva SI; Mazur VV; Kalinkin MN; Mazur ES
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (5):72-6. PubMed ID: 22145354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure.
    Vaz Pérez A; Doehner W; von Haehling S; Schmidt H; Zimmermann AV; Volk HD; Anker SD; Rauchhaus M
    Int J Cardiol; 2010 May; 141(1):39-43. PubMed ID: 19155075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure.
    Yamazaki T; Lee JD; Shimizu H; Uzui H; Ueda T
    Eur J Heart Fail; 2004 Jan; 6(1):41-5. PubMed ID: 15012917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of rhubarb on the intestinal barrier function of patients with acute myocardial infarction-heart].
    Mao XB; Wang SQ; Mao Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Aug; 32(8):1046-50. PubMed ID: 23173250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.